Lars Gunneflo, Board Member
Lars Gunneflo is CEO at Gunneflo Life Science, Senior advisor and management consultant, with more than 35 years of experience from executive roles, in Pharma, Medtech, Diagnostic and Pharmacy businesses, in Sweden and abroad. Broad experience within M&A, management and development of companies in early stage and “ready for market”, companies.
Anna Viking, Deputy
Anna Viking holds bachelor in International Marketing from Luleå University of technology and Nanyang Technological Univeristy. Anna works in the search marketing industry as a Senior Account Manager.
Jesper Mehlsen, Board Member
Jesper Mehlsen, MD, is a specialist in Clinical Physiology & Nuclear Medicine. In addition to experience in human experimental and clinical scientific studies from the University Hospitals in Copenhagen. Jesper has experience in clinical drug related studies from the Medical Industry active within the indications of hypertension, heart disease and diabetes.
Ingela Wiking, Board Member
Ingela Wiking is the owner and CEO of IRW Consulting AB, a CRO based in Stockholm, Sweden. Ms. Wiking, worked for several years in the pharmaceutical and CRO industry, performing various clinical development functions, focusing primarily on three therapeutic areas: Diabetes, cardiovascular, and infectious disease. She founded IRW in 1999. Under her management and leadership, IRW has grown to a full-service CRO providing clinical development support to biotech, pharmaceutical, and medical device companies throughout the Scandinavian region.
Tommy Adamsson, Chairman of the board
CEO of Adamssongruppen AB and director or chairman of the board of several commercial companies in the retail- service- and financial sectors and NGOs. Specialties: Corporate governance, competitive and strategical analysis, financing, franchising, mergers and acquisitions.
